Kratom, a plant-derived substance with opioid-like effects, faces renewed scrutiny as Robert F. Kennedy Jr. seeks to ban a key ingredient known as 7-OH. MAHA’s decision to back one side in this intensifying debate underscores the conflict’s potential to shape future health policy.